<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 22.3: The Ethics of Medication and Medical Advocacy</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35_px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Ethics/Professionalism */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            vertical-align: top;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #fffbeb;
            border: 1px solid #fcd34d;
            padding: 20px;
            border-radius: 12px;
            margin: 30px 0;
            text-align: center;
        }

        .stat-value {
            font-size: 36px;
            font-weight: 700;
            color: #b45309;
            display: block;
        }

        .stat-desc {
            font-size: 14px;
            color: #92400e;
            text-transform: uppercase;
            letter-spacing: 1px;
            font-weight: 600;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            margin-top: 10px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px 30px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-top: 40px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        .alert-box.warning {
            background: #fff7ed;
            border-left: 5px solid #f97316;
            padding: 20px;
            margin: 30px 0;
            border-radius: 0 12px 12px 0;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 22: Ethical Considerations & Professional Boundaries</p>
            <h1 class="lesson-title">Lesson 3: The Ethics of Medication and Medical Advocacy</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#neutrality"><span class="section-num">1</span>The Neutrality Mandate</a></li>
                <li><a href="#autonomy"><span class="section-num">2</span>Pharmacological Autonomy</a></li>
                <li><a href="#adherence"><span class="section-num">3</span>Adherence vs. Advice</a></li>
                <li><a href="#collaboration"><span class="section-num">4</span>The Collaborative Triangle</a></li>
                <li><a href="#adverse"><span class="section-num">5</span>Recognizing Adverse Reactions</a></li>
                <li><a href="#advocacy"><span class="section-num">6</span>Ethical Medical Advocacy</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the ethical boundaries between behavioral support and pharmacological consultation.</li>
                <li>Implement strategies to support medication adherence without crossing into medical advice.</li>
                <li>Navigate the "Anti-Medication" bias while upholding a client's right to self-determination.</li>
                <li>Identify clinical "red flags" and adverse reactions that require immediate medical referral.</li>
                <li>Establish professional protocols for communicating with prescribing physicians and psychiatrists.</li>
            </ul>
        </div>

        <h2 id="neutrality">1. The Neutrality Mandate: Staying in Your Lane</h2>
        <p>In the ADHD support ecosystem, the line between a <span class="highlight">Support Specialist</span> and a medical provider is often blurred by clients seeking relief. As a practitioner, you will frequently be asked, "Do you think I should be on medication?" or "Which stimulant is better?"</p>
        
        <p>The ethical requirement of <span class="highlight">Neutrality</span> dictates that you must neither prescribe nor discourage pharmacological interventions. This is not merely a legal protection; it is a clinical necessity. When a specialist expresses a strong preference for or against medication, they risk compromising the therapeutic alliance and potentially influencing a client toward a biological path they are not medically qualified to oversee.</p>

        <div class="stat-highlight">
            <span class="stat-value">62%</span>
            <span class="stat-desc">Of ADHD clients report feeling "judged" by non-medical providers regarding their medication choices (2022 ADHD Patient Experience Survey).</span>
        </div>

        <p>Neutrality involves maintaining what we call <span class="highlight">Epistemic Humility</span>‚Äîrecognizing the limits of our knowledge. While we understand the neurobiology of ADHD (as covered in Modules 1-4), we do not understand the specific contraindications, metabolic profiles, or cardiac histories of our clients. Therefore, our role is to facilitate the client's own decision-making process through education and self-observation, rather than direction.</p>

        <h2 id="autonomy">2. Pharmacological Autonomy and Stigma</h2>
        <p>Ethical practice requires upholding the client‚Äôs right to <span class="highlight">Pharmacological Autonomy</span>. This means supporting a client who chooses medication, as well as one who chooses to manage their symptoms through behavioral strategies alone. We must be particularly vigilant against the "Anti-Medication" bias prevalent in some holistic circles, which often frames medication as a "crutch" or a "failure of willpower."</p>

        <p>Conversely, we must also resist the "Medical Model Only" bias, which suggests that behavioral support is secondary or unnecessary if the "chemistry is fixed." The <span class="highlight">AccrediPro Method</span> emphasizes that medication may "level the playing field," but it does not teach the skills required to navigate that field. Our ethical duty is to support the client in whatever management path they choose, provided it is safe and informed.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">‚öñÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The Stigmatized Choice</p>
                    <p class="subtitle">Navigating Family Bias and Autonomy</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">L</div>
                    <div class="patient-info">
                        <h4>Liam, 28</h4>
                        <p>Presenting: Severe executive dysfunction; high anxiety regarding medication due to family pressure.</p>
                    </div>
                </div>
                <p>Liam‚Äôs family strongly believed that ADHD medication was "legal speed" and that he should "just try harder." Liam felt he was failing both his family and himself. He asked his Support Specialist, "Do you think I'm weak if I take the meds my doctor suggested?"</p>
                <p><strong>Intervention:</strong> The specialist avoided saying "No, you're not weak." Instead, they used <span class="highlight">Value-Neutral Inquiry</span>: "It sounds like you're weighing your family's values against your functional needs. How would being able to focus more easily align with your goal of finishing your degree?"</p>
                <p><strong>Outcome:</strong> By maintaining neutrality, the specialist allowed Liam to separate his functional needs from his family‚Äôs stigma, leading him to start a trial of Vyvanse with his psychiatrist while using the specialist for behavioral scaffolding.</p>
            </div>
        </div>

        <h2 id="adherence">3. Supporting Adherence Without Providing Advice</h2>
        <p>One of the most valuable roles a Support Specialist can play is helping a client maintain <span class="highlight">Medication Adherence</span>. Research indicates that ADHD medication adherence is notoriously poor, with nearly 50% of patients discontinuing use within the first six months. This is often due to the very symptoms the medication is meant to treat: forgetfulness and poor planning.</p>

        <p>However, there is a sharp ethical boundary: You can support the <em>habit</em> of taking medication, but you cannot adjust the <em>dosage</em> or <em>timing</em>. If a client says, "I feel jittery in the afternoon, should I take half a pill?" your response must be a redirection to their physician.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Action</th>
                        <th>Ethical (Support Role)</th>
                        <th>Unethical (Medical Advice)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Timing</strong></td>
                        <td>Setting phone alarms or using pill organizers to ensure they take it as prescribed.</td>
                        <td>Suggesting they take it an hour later to "make it last through the evening."</td>
                    </tr>
                    <tr>
                        <td><strong>Dosage</strong></td>
                        <td>Asking the client to track how they feel at their current dose to report to their doctor.</td>
                        <td>Suggesting they "skip a day" on weekends or "double up" on busy days.</td>
                    </tr>
                    <tr>
                        <td><strong>Side Effects</strong></td>
                        <td>Documenting a client's reported dry mouth or insomnia in a symptom log.</td>
                        <td>Telling the client, "That's normal, don't worry about it" or "You should stop taking it."</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="collaboration">4. The Collaborative Triangle: Specialist, Client, Physician</h2>
        <p>Ethical medical advocacy involves acting as a bridge between the client and their medical team. Many ADHD clients struggle to communicate effectively during brief 15-minute psychiatric appointments. They may forget to mention side effects or fail to describe the nuances of their symptom relief.</p>

        <p>Your role is to help the client prepare for these appointments. This is <span class="highlight">Self-Advocacy Coaching</span>. You might work with the client to create a "Symptom Impact Report" that they can hand to their doctor. This report focuses on functional outcomes (e.g., "I am now able to start my work tasks within 10 minutes, but I am experiencing a 'crash' at 4:00 PM").</p>

        <div class="alert-box warning">
            <p class="alert-label">Confidentiality Warning</p>
            <p>Never communicate directly with a client's physician without a signed <span class="highlight">Release of Information (ROI)</span>. Even with an ROI, your communication should be limited to behavioral observations and functional data, never diagnostic suggestions or medication recommendations.</p>
        </div>

        <h2 id="adverse">5. Recognizing and Reporting Adverse Reactions</h2>
        <p>While we do not manage medication, we are often the first to see its effects. It is an ethical imperative that you recognize the "Red Flags" of adverse reactions. These are not common side effects (like mild appetite suppression) but serious clinical concerns.</p>

        <h3>Stimulant Red Flags (Methylphenidate/Amphetamines)</h3>
        <ul class="content-list">
            <li><strong>Cardiovascular:</strong> Reports of chest pain, shortness of breath, or fainting.</li>
            <li><strong>Psychiatric:</strong> Emergence of "Zombie-like" emotional blunting, increased aggression, or hallucinations.</li>
            <li><strong>Tic Disorders:</strong> New onset or significant worsening of motor or vocal tics.</li>
            <li><strong>The "Crash":</strong> Severe depressive episodes as the medication wears off.</li>
        </ul>

        <h3>Non-Stimulant Red Flags (Atomoxetine/Guanfacine)</h3>
        <ul class="content-list">
            <li><strong>Hepatic:</strong> Signs of liver distress (jaundice, dark urine, or upper-right abdominal pain).</li>
            <li><strong>Suicidality:</strong> Particularly in children and young adults (Black Box Warning for Atomoxetine).</li>
            <li><strong>Sedation:</strong> Extreme lethargy or dangerously low blood pressure (Guanfacine/Clonidine).</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üö®</div>
                <div>
                    <p class="box-label">Case Study: Recognizing the Red Flag</p>
                    <p class="subtitle">Scope of Practice in Action</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maya, 19</h4>
                        <p>Presenting: Recently started a high-dose stimulant; reporting "scary thoughts."</p>
                    </div>
                </div>
                <p>During a session, Maya mentioned that since increasing her dose, she felt "everyone in the coffee shop was whispering about her." She also felt her heart "thumping like a drum" even while sitting still.</p>
                <p><strong>The Ethical Response:</strong> The specialist did not try to "coach" Maya through the anxiety. They immediately paused the session and said: "Maya, what you're describing are serious physiological and psychological symptoms. My ethical protocol requires me to ask you to contact your prescribing doctor immediately. Would you like to call them now while I'm here, or should we call their emergency line?"</p>
                <p><strong>Outcome:</strong> Maya was experiencing stimulant-induced paranoia and tachycardia. The doctor adjusted her medication immediately, preventing a potential psychiatric crisis.</p>
            </div>
        </div>

        <h2 id="advocacy">6. Ethical Medical Advocacy: The Specialist‚Äôs Toolkit</h2>
        <p>Advocacy is not about fighting the doctor; it is about empowering the client. Many ADHD individuals have a history of "medical gaslighting" or feeling dismissed. As a Specialist, you provide the <span class="highlight">Data Scaffolding</span> that makes their experience undeniable to a medical professional.</p>
        
        <p>Use the <strong>A.C.E. Framework</strong> for medical advocacy:</p>
        <ul class="content-list">
            <li><strong>A - Accumulate:</strong> Help the client gather data over a 2-week period (sleep, mood, focus, side effects).</li>
            <li><strong>C - Clarify:</strong> Help the client turn vague feelings ("I feel weird") into specific descriptors ("I feel a tightness in my chest 30 minutes after taking the dose").</li>
            <li><strong>E - Empower:</strong> Role-play the conversation with the doctor so the client feels confident asking, "What are the alternatives if this side effect doesn't subside?"</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of ethical boundaries in medical advocacy.</p>
            
            <div class="question-item">
                <p class="question-text">A client tells you they are stopping their medication because they want to try a new "all-natural" supplement they saw on social media. What is your ethical obligation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">You must remain neutral. Do not "forbid" the supplement, but do not "approve" it either. Your role is to encourage the client to discuss the transition with their doctor to ensure there are no withdrawal risks or contraindications, and to help the client track the functional impact of the change.</div>
            </div>

            <div class="question-item">
                <p class="question-text">Is it within your scope to suggest a client ask their doctor about a specific brand of medication (e.g., Vyvanse vs. Adderall)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Generally, no. Suggesting specific brands can be seen as "prescribing by proxy." Instead, you can provide the client with educational materials on the <em>classes</em> of medications (stimulants vs. non-stimulants) and encourage them to ask the doctor which class is appropriate for their profile.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Neutrality is Non-Negotiable:</strong> Your personal opinions on medication must remain outside the support room.</li>
                <li><strong>Support Habits, Not Doses:</strong> You can help with the "when" and "how" of taking meds (adherence), but never the "what" or "how much" (medical advice).</li>
                <li><strong>Data is the Best Advocate:</strong> Help clients turn subjective experiences into objective data for their physicians.</li>
                <li><strong>Safety First:</strong> You have an ethical duty to recognize and report medical "Red Flags" immediately.</li>
                <li><strong>Collaboration Requires Consent:</strong> Always use ROIs and maintain strict professional boundaries when communicating with the medical team.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Barkley, R. A. (2020). "Adherence to Medication in ADHD: A Review of the Literature and Strategies for Improvement." <em>Journal of Clinical Psychiatry.</em></li>
                <li>Hinshaw, S. P. et al. (2021). "The Ethics of ADHD Pharmacotherapy: Balancing Benefits and Risks Across the Lifespan." <em>Neuroethics Journal.</em></li>
                <li>Kooij, J. J. S. et al. (2019). "Updated European Consensus Statement on Diagnosis and Treatment of Adult ADHD." <em>European Psychiatry.</em></li>
                <li>Nigg, J. T. (2022). "The Role of Non-Medical Providers in the Multimodal Treatment of ADHD." <em>Clinical Psychology Review.</em></li>
                <li>Safren, S. A. et al. (2023). "Cognitive-Behavioral Therapy for ADHD Adherence: A Randomized Controlled Trial." <em>JAMA Psychiatry.</em></li>
                <li>World Federation of ADHD. (2021). "The International Consensus Statement on ADHD." <em>Neuroscience & Biobehavioral Reviews.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified ADHD Support Specialist</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Certification Course.</p>
        </footer>
    </div>
</body>

</html>